文献速递外周动脉疾病

冷冻保存同种异体移植物治疗无自体大隐静脉的慢性肢体威胁性缺血

Cryopreserved Allografts for Treatment of Chronic Limb-Threatening Ischemia in Patients Without Autologous Saphenous Veins.
PubMed 文献 · Ann Vasc Surg · 2019-06-11

该研究回顾性分析西班牙加泰罗尼亚地区1995年至2014年登记库中149例无合适自体静脉的慢性肢体威胁性缺血(CLI)患者,采用冷冻保存动脉同种异体移植物行腹股沟下旁路术。结果显示5年一期通畅率38.6%、保肢率50.2%,总体移植物闭塞率52.3%,结论认为该移植物虽为次优选择,但部分筛选患者仍可获益。

要点

  • 冷冻保存动脉同种异体移植物5年一期通畅率38.6%,保肢率50.2%。
  • 总体移植物闭塞率52.3%,感染率6%,扩张率5.4%。
  • 远端靶血管重建是保肢率和一期通畅率较低的独立预测因素。

核心结论

  • 动脉同种异体移植物虽为次优选择,但部分筛选的CLI患者仍可从中获益。
  • 5年结果令人失望,需更多研究以确定其他预测因素以更好地筛选患者。

研究设计与样本

  • 回顾性分析西班牙加泰罗尼亚自治区血管和瓣膜同种异体移植物移植登记库(1995年1月至2014年1月)。
  • 纳入149例需行腹股沟下旁路术的CLI患者,平均年龄70.1岁。

主要发现

  • 总体随访中24.8%患者需再次干预。
  • 总体移植物闭塞率52.3%,感染率6%,扩张率5.4%。
  • 总体30天死亡率为0.7%。
  • 5年一期通畅率38.6%,保肢率50.2%,生存率54.2%,无主要不良肢体事件(MALE)率21.5%。
  • 远端靶血管重建是保肢率和一期通畅率较低的独立阳性预测危险因素;血脂异常与较低保肢率相关,是MALE的危险因素。

临床怎么用

  • 对于无合适自体大隐静脉的CLI患者,可考虑使用冷冻保存动脉同种异体移植物作为腹股沟下旁路 conduit。
  • 应告知患者该移植物5年通畅率和保肢率较低,需谨慎筛选获益人群。

局限性

  • 回顾性登记库分析,可能存在选择偏倚和信息偏倚。
  • 样本量有限(149例),结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Revascularization is the best alternative to reduce symptoms and to improve the limb salvage rate in patients with chronic limb-threatening ischemia (CLI). Alternative grafts as synthetic prostheses and allografts must be considered for patients without a suitable autologous graft. Our aim was to evaluate outcomes of cryopreserved allografts used as a vascular conduit for bypass surgery in the infrainguinal territory. METHODS: A retrospective analysis (January 1995 to January 2014) of the Registry of vascular and valvular allografts transplant in the autonomous community of Catalonia, Spain was performed for identifying patients with CLI who required infrainguinal bypass with cryopreserved arterial allografts. Statistical analysis was performed using SPSS, ver. 20, for Mac (Chicago). RESULTS: A total of 149 patients with CLI (mean age of 70.1 years) were analyzed. One hundred two patients (68.5%) had a grade IV lesion (Fontaine classification). In the overall follow-up, 24.8% of patients required a reintervention. Overall graft occlusion, infection, and dilation rate were 52.3%, 6%, and 5.4% respectively. Overall 30-day mortality was 0.7%. Five-year primary patency rate and limb salvage rate were 38.6% and 50.2%, respectively. Survival rate at 5 years was 54.2%. Major adverse limb event (MALE)-free rate was 21.5% at 5 years. Revascularization to a distal target vessel was an independent positive predictive risk factor for a lower limb salvage rate and lower primary patency rate. Dyslipidemia was related to a lower limb salvage rate and represents a risk factor involved in MALEs. CONCLUSIONS: Although arterial allografts seem to represent a suboptimal alternative, some selected patients could beneficiate from them. Five-year results are disappointing, and more studies are required to know other predictive factors for better selection of patients.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Guevara-Noriega KA, Lucar-Lopez GA, Pomar JL, et al. Cryopreserved Allografts for Treatment of Chronic Limb-Threatening Ischemia in Patients Without Autologous Saphenous Veins. Ann Vasc Surg. 2019. PMID: 31200034. doi:10.1016/j.avsg.2019.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。